Investors realize that the greatest return on investment is often obtained through emerging technologies; however, such technologies are imbued with a significant risk of failure, and bankers, angel investors, brokers-dealers, buyers, sellers, and venture capitalists are wisely risk averse. We tip the balance in their favor. Our reports have been part of successful transactions valuated at up to hundreds of millions of dollars. They have helped companies secure financing, accomplish profitable exit strategies, and even go public.
Innovar provides technology evaluation (not “valuation”) services. We evaluate the technical robustness, commercial feasibility and level of protection for target emerging technologies. When patents are involved, we determine the strength of protection in terms of patentability, claimed scope of coverage, difficulty of patent circumvention, potential invalidity, domination, and more. Even in the absence of patents, we evaluate technologies to determine whether the underlying scientific and technical features have merit to ensure the technology is not merely a confusing amalgam of “smoke and mirrors”. Here’s a bit more about our due diligence reports.
Technology Report
Small to mid-sized companies usually build their entire business around a target technology. Often times, a better understanding of the technological merits of the target technology is needed to facilitate informed decision-making. In the medical device and pharmaceutical (human or animal) arenas, however, the target technologies are often complex enough that it may be difficult to determine their technical feasibility, scientific soundness, and potential for commercialization.
Our technology report provides an overview of the target technology with an emphasis on whether it is technically feasible, is based upon scientifically sound and proven principles according to the current state-of-the-art, and/or has potential for commercialization. This latter aspect of the report may also be expanded to include discussion regarding potential regulatory hurdles that the target technology may need to address before commercialization.
Intellectual Property Report
Patent protection of a target technology is key to protection of the underlying financial investments made toward advancing the technology. So, companies often create patent portfolios protecting various aspects of that technology. Unfortunately, those same companies often overstate the scope of patent protection. The portfolios often focus on the number of patent filings rather than on the quality and breadth of protection provided by the patent portfolio.
Our intellectual property report provides an overview of the quality and breadth of protection provided by the patent portfolio. We conduct a detailed review of patent claims, enablement, ease of circumvention, and more. If needed, our report can be expanded to include a preliminary determination of the patentability of the technology based upon the current state-of-the-art and to include a detailed analysis of the prosecution history of specific patents. We are also able to expand our analysis into foreign patents of a target patent portfolio.
Protect capital. Reduce risk. Engage our patent and technology evaluation service today.